Prognostic Significance of Preoperative Serum Alpha-fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China |
An, Song-Lin
(Department of Abdominal Surgical Oncology, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
Xiao, Ting (Department of Etiology and Carcinogenesis, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences) Wang, Li-Ming (Department of Abdominal Surgical Oncology, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences) Rong, Wei-Qi (Department of Abdominal Surgical Oncology, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences) Wu, Fan (Department of Abdominal Surgical Oncology, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences) Feng, Li (Department of Abdominal Surgical Oncology, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences) Liu, Fa-Qiang (Department of Abdominal Surgical Oncology, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences) Tian, Fei (Department of Abdominal Surgical Oncology, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences) Wu, Jian-Xiong (Department of Abdominal Surgical Oncology, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences) |
1 |
Bertino G, Neri S, Bruno CM, et al (2011). Diagnostic and prognostic value of alpha-fetoprotein, des- |
2 | Bois-Joyeux B, Danan JL (1994). Members of the CAAT/enhancer binding protein, hepatocyte nuclear factor-1 and nuclear factor-1 families can differentially modulate the activities of the rat alpha fetoprotein promoter and enhancer. Biochem J, 301, 49-55. DOI |
3 | Bosetti C, Levi F, Boffetta P, et al (2008). Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology, 48, 137-45. DOI ScienceOn |
4 | Center MM, Jemal A (2011). International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev, 20, 2362-8. DOI |
5 | Chan SL, Chan AT, Yeo W (2009). Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both? Future Oncol, 5, 889-99. DOI |
6 | Crowe AJ, Sang L, Li KK, et al (1999). Hepatocyte nuclear factor 3 relieves chromatin-mediated repression of the alphafetoprotein gene. J Biol Chem, 274, 25113-20. DOI |
7 | Debruyne EN, Delanghe JR (2008). Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. Clin Chim Acta, 395, 19-26. DOI |
8 | El-Serag HB (2011). Hepatocellular carcinoma. N Engl J Med, 365, 1118-27. DOI ScienceOn |
9 | Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. DOI |
10 | Forner A, Vilana R, Ayuso C, et al (2008). Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology, 47, 97-104. |
11 | Giannini EG, Marenco S, Borgonovo G, et al (2012). Alphafetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. Hepatology, 56, 1371-9. |
12 | Gupta S, Bent S, Kohlwes J (2003). Test characteristics of alpha fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med, 139, 46-50. DOI |
13 | Haibin Z, Yue J, Yaxian X (2010). Primary yolk sac tumor of the omentum: a case report and literature review. Eur J Gynaecol Oncol, 31, 682-4. |
14 | Ikai I, Arii S, Kojiro M, et al (2004). Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer, 101, 796-802. DOI |
15 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
16 | Kim do Y, Han KH (2012). Epidemiology and surveillance of hepatocellular carcinoma. Liver Cancer, 1, 2-14. DOI |
17 | Kojima K, Takata A, Vadnais C, et al (2011). MicroRNA122 is a key regulator of alpha fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. Nat Commun, 2, 338. DOI |
18 | Lee SS, Shin HS, Kim HJ, et al (2012). Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience. Korean J Hepatol, 18, 48-55. DOI ScienceOn |
19 | Li MS, Li PF, Yang FY, et al (2002). The intracellular mechanism of alpha-fetoprotein promoting the proliferation of NIH 3T3 cells. Cell Res, 12, 151-6. DOI |
20 | Li P, Wang SS, Liu H, et al (2011). Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma. World J Gastroenterol, 17, 4563-71. DOI |
21 | Li T, Qin LX, Gong X, et al (2014). Clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence of female patients after curative resection of hepatocellular carcinoma. Surgery, 156, 651-60. DOI |
22 | Meng W, Li X, Bai Z, et al (2014). Silencing alpha-fetoprotein inhibits VEGF and MMP-2/9 production in human hepatocellular carcinoma cell. PLoS One, 9, 90660. DOI |
23 | Nakagawa K, Koike S, Matsumura H, et al (2012). Alphafetoprotein producing rectal cancer. Gan To Kagaku Ryoho, 39, 671-4. |
24 | Nomura F, Ohnishi K, Tanabe Y (1989). Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer, 64, 1700-7. DOI |
25 | Ogden SK, Lee KC, Barton MC (2000). Hepatitis B viral transactivator HBx alleviates p53-mediated repression of alpha-fetoprotein gene expression. J Biol Chem, 275, 27806-14. |
26 | Peng SY, Chen WJ, Lai PL, et al (2004). High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int J Cancer, 112, 44-50. DOI |
27 | Sangiovanni A, Del Ninno E, Fasani P, et al (2004). Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology, 126, 1005-14. DOI |
28 | Sung WK, Zheng H, Li S, et al (2012). Genomewide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet, 44, 765-9. DOI ScienceOn |
29 | Savastano S, Miotto D, Casarrubea G, et al (1999). Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors. J Clin Gastroenterol, 28, 334-40. DOI |
30 | Sugita S, Sasaki A, Iwaki K, et al (2008). Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: a retrospective study. Eur J Surg Oncol, 34, 339-45. DOI |
31 | Tomasi TB Jr (1977). Structure and function of alpha-fetoprotein. Annu Rev Med, 28, 453-65. DOI |
32 | Yang X, Zhang Y, Zhang L, et al (2008). Silencing alphafetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell. Cancer Lett, 271, 281-93. DOI |
33 | Yu W, Rong W, Wang L et al (2014). R1 hepatectomy with exposure of tumor surface for centrally located hepatocellular carcinoma. World J Surg, 38, 1777-85. DOI |
34 | Yuen MF, Tanaka Y, Fong DY, et al (2009). Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol, 50, 80-8. DOI |
35 | Zhang XF, Qi X, Meng B, et al (2010). Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems. Eur J Surg Oncol, 36, 718-24. DOI |
36 | Zhou J, Yan T, Bi X, et al (2013). Evaluation of seven different staging systems for alpha-fetoprotein expression in hepatocellular carcinoma after hepatectomy. Tumor Biol, 34, 1061-70. DOI |
![]() |